CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. : Change of Directors or Principal Officers, Financial Statements and Exhibits (Form 8-K)

0

Article 5.02 Departure of directors or certain officers; Election of directors; Appointment of certain leaders; Compensatory provisions of certain executives.

At February 9, 2022after approval by its Compensation Committee,
Creative Medical Technology Holdings, Inc. (the “Company”) has entered into written employment agreements (the “Employment Agreements”) with Timothy Warbington, the Chief Executive Officer of the Company; and Donald Dickerson, the chief financial officer of the company (together, the “executives”). The employment contracts are identical in all material respects except with respect to base salary, which remains $330,000 per year for Mr. Warbingtonand $300,000 per year for Mr. Dickerson.

Additional terms of employment contracts include the following:


       ·   Each Employment Agreement is for a three year term, subject to
           automatic renewal for successive three-year periods unless either party
           provides notice of non-renewal prior to the then end of the term.

       ·   Each Executive is entitled to an annual cash bonus targeted at 30% of
           his base salary.

       ·   Each Executive is entitled to an annual grant of an option to purchase
           a number of shares of common stock of the Company with a value as of
           the date of grant of 30% of the Executive's base salary, vesting over a
           three year period. The initial stock option grant under each Employment
           Agreement was made on February 9, 2022.

       ·   In the event of the termination of the Executive's employment by the
           Company other than for Cause, or by the Executive for Good Reason (as
           such terms are defined in the Employment Agreement), the Executive will
           be entitled to continued payment of base salary and annual bonuses for
           two years.



The foregoing is a summary of the terms of the employment contracts, does not purport to be complete, and is submitted and qualified in its entirety by reference to the text of those agreements, which have been filed as attachments to this current report on form 8-K.

Item 9.01  Financial Statements and Exhibits.



(d) Exhibits.



  10.1        Employment Agreement between the Company and Timothy Warbington,
            dated as of February 9, 2022.

  10.2        Employment Agreement between the Company and Donald Dickerson, dated
            as of February 9, 2022.

104         Cover Page Interactive Data File (embedded within the Inline XBRL
            document)





2

© Edgar Online, source Previews


Source link

Share.

Comments are closed.